Healthcare & Life Sciences

TaiLai Biosciences

China
Sign in to unlock

About

Develops liquid biopsy assays using a proprietary multi-omics platform. The company markets products intended for earlier cancer detection and for diagnosis/treatment in the early stages of disease.

Explore TaiLai Biosciences's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing